Interleukin-5
IL5geneEosinophil-recruiting cytokine implicated in atherogenic immune response and plaque inflammation.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleCAD-associated cytokine; eosinophil recruitment and immune modulation in plaque.
Druggability
DruggableYes
Known drugs / candidates3
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000113525
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I52
C — confounder / Type-II84
A — assay feasibility52
E — evidence strength31
T1DI (composite)6
Specificity differential (R−C)-31.7
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(2)
- Multi-ancestry genetic analysis of gene regulation in coronary arteries prioritizes disease risk loci.Cell genomics · 2023 · PMID 38190101 · doi
- IL-33 reduces the development of atherosclerosis.The Journal of experimental medicine · 2008 · PMID 18268038 · doi